Abingdon Health Plc

Research Abingdon Health Plc (ABDX) on Bullrun: market cap GBX 2.70B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is GBX 2.70B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025GBP 8.43M-GBP 3.42M-GBP 3.53M44.3%-0.01GBP 1.92MGBP 1.03MGBP 5.30M
FY2024GBP 6.14M-GBP 1.27M-GBP 1.70M60.0%0GBP 1.44MGBP 1.05MGBP 2.25M
FY2023GBP 4.05M-GBP 3.47MGBP 756.00K51.3%-0.01GBP 3.24MGBP 1.02MGBP 2.97M
FY2022GBP 2.84M-GBP 21.26M-GBP 8.50M-126.7%-0.07GBP 2.40MGBP 1.28MGBP 6.41M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24GBX 2.70Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 GBX.

About Abingdon Health Plc

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Abingdon Health Plc's market cap?

Abingdon Health Plc's market capitalization is GBX 2.70B.

What does Abingdon Health Plc do?

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.